News Highlights: Top Company News of the Day
April 12 2021 - 1:30PM
Dow Jones News
Microsoft's Shopping Spree Isn't Landing Bargains
The acquisition of Nuance Communications adds to AI capabilities
but represents a high price for a struggling business.
Jack Ma's Ant Group Bows to Beijing With Company Overhaul
Ant Group, the financial-technology giant controlled by
billionaire Jack Ma, will apply to become a financial holding
company overseen by China's central bank.
Uber Posts Record Demand in March
Gross bookings for the entire business, which includes rides and
food delivery, rose to the highest monthly level in Uber's history
as Covid-19 vaccinations pick up.
Cybersecurity Firm Darktrace Targets $4 Billion London IPO
Darktrace said it aims to go public in London, hoping to cash in
on growing demand for its software despite ongoing legal
uncertainty over one of its leading backers.
Chip Shortage Is Bad for GM but Worse for Car Buyers
The shortage of semiconductors is worsening, but might need to
drag out indefinitely to have a more noticeable impact on auto
stocks.
Boeing Shareholders Will Weigh Need for More Changes to Board
The plane maker has changed the membership and structure of its
board since a second 737 MAX airliner crashed two years ago.
Investors will soon decide whether the company has done enough.
Huawei, HSBC Strike Deal Over Documents in Extradition Fight
Huawei Chief Financial Officer Meng Wanzhou believes the
documents will help in her battle against extradition from Canada
to the U.S. on charges related to alleged sanctions-busting sales
to Iran.
Credit Suisse Faces Tough Choices on Investment Bank
Credit Suisse's investment bank is the Swiss lender's profit
engine. But after the Archegos and Greensill meltdowns, it is
expected to be scaled back for safety.
French Firms Reach $15.5 Billion Deal to Create Water, Waste Behemoth
France's Veolia Environnement agreed to acquire Suez, creating a
water and waste-management giant that aims to soak up a global
surge in infrastructure and climate-change spending.
Regeneron Drug Stops Symptomatic Covid-19 in Study
The antibody drug reduced the risk of developing symptomatic
Covid-19 infection by 81% compared with a placebo in people living
with someone infected by the new coronavirus, a study found.
(END) Dow Jones Newswires
April 12, 2021 13:15 ET (17:15 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.